Peptide therapeutics from venom: Current status and potential

Area of Science:

• Biochemistry
• Pharmacology
• Toxicology

Background:

• Peptides are valuable therapeutic candidates due to their high selectivity, potency, and safety profiles.
• Animal venoms are a rich source of unique peptides with diverse biological activities.
• Current clinical applications of venom-derived peptides are limited but expanding.

Purpose of the Study:

• To explore the therapeutic potential of peptides derived from animal venoms.
• To highlight the growing opportunities for venom-derived peptides in various industries.
• To discuss the impact of advanced sequencing techniques on venom peptide discovery.

Main Methods:

• Review of existing literature on venom-derived peptides.
• Analysis of proteomic and transcriptomic data for novel peptide identification.
• Assessment of peptide properties for therapeutic and other applications.

Main Results:

• Venom-derived peptides exhibit high selectivity and potency, with manageable safety profiles at appropriate concentrations.
• Proteomic and transcriptomic approaches are continuously identifying new venom peptide sequences.
• The identified peptides show potential for development into therapeutics, cosmetics, and insecticides.

Conclusions:

• Venom-derived peptides represent a promising class of compounds for drug development.
• Technological advancements are accelerating the discovery and application of these peptides.
• The future prospects for venom-derived peptides in medicine and industry are optimistic.